163 related articles for article (PubMed ID: 33512331)
1. Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic review.
Ahmad S; Naber MR; Giles RH; Valk GD; van Leeuwaarde RS
Endocr Relat Cancer; 2021 Mar; 28(3):151-160. PubMed ID: 33512331
[TBL] [Abstract][Full Text] [Related]
2. The utility of
Shell J; Tirosh A; Millo C; Sadowski SM; Assadipour Y; Green P; Patel D; Nilubol N; Kebebew E
Eur J Radiol; 2019 Mar; 112():130-135. PubMed ID: 30777201
[TBL] [Abstract][Full Text] [Related]
3.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Kitano M; Millo C; Rahbari R; Herscovitch P; Gesuwan K; Webb RC; Venkatesan AM; Phan GQ; Hughes MS; Libutti SK; Nilubol N; Linehan WM; Kebebew E
Surgery; 2011 Dec; 150(6):1122-8. PubMed ID: 22136831
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease.
Keutgen XM; Hammel P; Choyke PL; Libutti SK; Jonasch E; Kebebew E
Nat Rev Clin Oncol; 2016 Sep; 13(9):537-49. PubMed ID: 27030075
[TBL] [Abstract][Full Text] [Related]
6. Potential value of EUS in pancreatic surveillance of VHL patients.
van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Koopmans KP; Kema IP; Zonnenberg BA; Timmers HJ; de Herder WW; Sluiter WJ; de Vries EG; Links TP
Eur J Endocrinol; 2016 May; 174(5):611-20. PubMed ID: 26884551
[TBL] [Abstract][Full Text] [Related]
7. Potential role of (68)Ga-DOTATOC PET/CT in screening for pancreatic neuroendocrine tumour in patients with von Hippel-Lindau disease.
Prasad V; Tiling N; Denecke T; Brenner W; Plöckinger U
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2014-20. PubMed ID: 27293206
[TBL] [Abstract][Full Text] [Related]
8. Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.
Weisbrod AB; Kitano M; Thomas F; Williams D; Gulati N; Gesuwan K; Liu Y; Venzon D; Turkbey I; Choyke P; Yao J; Libutti SK; Nilubol N; Linehan WM; Kebebew E
J Am Coll Surg; 2014 Feb; 218(2):163-9. PubMed ID: 24440063
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic organ-sparing resection of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
von Dücker L; Walz MK; Voss C; Arnold G; Eng C; Neumann HP
World J Surg; 2011 Mar; 35(3):563-7. PubMed ID: 21181474
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM
Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638
[TBL] [Abstract][Full Text] [Related]
11. Association of type O blood with pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Weisbrod AB; Liewehr DJ; Steinberg SM; Patterson EE; Libutti SK; Linehan WM; Nilubol N; Kebebew E
Ann Surg Oncol; 2012 Jun; 19(6):2054-9. PubMed ID: 22350603
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR
Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597
[TBL] [Abstract][Full Text] [Related]
13. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
[TBL] [Abstract][Full Text] [Related]
14. von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms.
Turcotte S; Turkbey B; Barak S; Libutti SK; Alexander HR; Linehan WM; Hughes MS; Nilubol N; Gesuwan K; Millo C; Quezado M; Choyke PL; Kebebew E; Phan GQ
Surgery; 2012 Dec; 152(6):1106-17. PubMed ID: 23107912
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Weisbrod AB; Kitano M; Gesuwan K; Millo C; Herscovitch P; Nilubol N; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2012 Apr; 97(4):E613-7. PubMed ID: 22259055
[TBL] [Abstract][Full Text] [Related]
17. Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?
Naber MR; Ahmad S; Verrijn Stuart AA; Giles RH; Valk GD; van Leeuwaarde RS
J Endocr Soc; 2022 Feb; 6(2):bvab191. PubMed ID: 35059546
[TBL] [Abstract][Full Text] [Related]
18. Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors.
Tirosh A; Journy N; Folio LR; Lee C; Leite C; Yao J; Kovacs W; Linehan WM; Malayeri A; Kebebew E; Berrington de González A
Radiology; 2019 Jan; 290(1):116-124. PubMed ID: 30299237
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
Marcos HB; Libutti SK; Alexander HR; Lubensky IA; Bartlett DL; Walther MM; Linehan WM; Glenn GM; Choyke PL
Radiology; 2002 Dec; 225(3):751-8. PubMed ID: 12461257
[TBL] [Abstract][Full Text] [Related]
20. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs).
Blansfield JA; Choyke L; Morita SY; Choyke PL; Pingpank JF; Alexander HR; Seidel G; Shutack Y; Yuldasheva N; Eugeni M; Bartlett DL; Glenn GM; Middelton L; Linehan WM; Libutti SK
Surgery; 2007 Dec; 142(6):814-8; discussion 818.e1-2. PubMed ID: 18063061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
